We would like to thank Biteker et al. [1] for their interest and positive and constructive comments regarding our case [2] . Peripartum cardiomyopathy (PPCMP) is a life-threatening clinical condition in which thromboembolic complications are frequent. Both the prothrombotic status of pregnancy and stasis as a result of heart failure may lead to thromboembolic complications [3] . The incidence of PPCMP and cardiac thrombus in literature is very variable. In one study, the incidence was reported to be 17%, while another study indicated 30% [4, 5] . It has even been reported in previous studies that up to 53% of cases of PPCMP have thromboembolism [6, 7] . In conclusion, the exact incidence of these patients is not known since they are both rare and could be diagnosed as a result of thromboembolic complications such as pulmonary embolism or ischemic stroke [8] .
The decision of anticoagulant therapy in PPCMP patients is still controversial, and the patient' s compliance, the degree of heart failure, and other clinical conditions should be taken into account when deciding on anticoagulant therapy [8] .
